FFCP PHASE2:Hg19::chr11:17298342..17298353,+
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p4@NUCB2 |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_4_at_NUCB2_5end |
| Coexpression cluster: | C1624_parotid_submaxillary_Mast_chronic_mesenchymal_acute_non |
| Association with transcript: | -24bp_to_ENST00000530964_5end |
| EntrezGene: | NUCB2 |
| HGNC: | 8044 |
| UniProt: | E9PLR5 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p4@NUCB2 |
|---|
0
5
10
15
20
25
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| leukemia | 2.56e-19 | 39 |
| organ system cancer | 7.43e-19 | 137 |
| myeloid leukemia | 4.76e-17 | 31 |
| hematologic cancer | 6.48e-16 | 51 |
| immune system cancer | 6.48e-16 | 51 |
| cancer | 2.08e-15 | 235 |
| disease of cellular proliferation | 5.64e-15 | 239 |
Showing 1 to 7 of 7 entries
